Search hospitals > Ohio > West Chester
University of Cincinnati Cancer Center-West Chester
Claim this profileWest Chester, Ohio 45069
Global Leader in Skin Cancer
Global Leader in Uterine Tumors
Conducts research for Relapse
Conducts research for Stomach Cancer
Conducts research for Lung Cancer
122 reported clinical trials
26 medical researchers
Summary
University of Cincinnati Cancer Center-West Chester is a medical facility located in West Chester, Ohio. This center is recognized for care of Skin Cancer, Uterine Tumors, Relapse, Stomach Cancer, Lung Cancer and other specialties. University of Cincinnati Cancer Center-West Chester is involved with conducting 122 clinical trials across 238 conditions. There are 26 research doctors associated with this hospital, such as Davendra P. Sohal, Trisha Wise-Draper, MD,PhD, Emily Curran, MD, and Shuchi Gulati, MD FACP.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
Stage II
2Uterine Tumors
Global LeaderStage IV
BRAF
HER2 negative
Top PIs
Davendra P. SohalUniversity of Cincinnati Medical Center5 years of reported clinical research
Studies Pancreatic Cancer
Studies Skin Cancer
24 reported clinical trials
45 drugs studied
Trisha Wise-Draper, MD,PhDUniversity of Cincinnati Medical Center4 years of reported clinical research
Studies Skin Cancer
Studies Squamous Cell Carcinoma
22 reported clinical trials
54 drugs studied
Emily Curran, MDUniversity of Cincinnati Cancer Center-UC Medical Center5 years of reported clinical research
Expert in T-Lymphoblastic Leukemia/Lymphoma
Studies Myeloid Leukemia
15 reported clinical trials
51 drugs studied
Shuchi Gulati, MD FACPUniversity of Cincinnati Medical Center2 years of reported clinical research
Studies Uterine Tumors
Studies Skin Cancer
13 reported clinical trials
26 drugs studied
Clinical Trials running at University of Cincinnati Cancer Center-West Chester
Skin Cancer
Lung Cancer
Esophageal Adenocarcinoma
Esophageal Carcinoma
Bladder Cancer
Prostate Cancer
Squamous Cell Carcinoma
Oropharyngeal Carcinoma
Breast Cancer
Gastroesophageal Junction Adenocarcinoma
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
MRI Monitoring vs. Preventive Brain Radiation
for Small Cell Lung Cancer
This phase III trial studies magnetic resonance imaging (MRI) surveillance and prophylactic cranial irradiation (PCI) to see how well they work compared to MRI surveillance alone in treating patients with small cell lung cancer. MRI scans are used to monitor the possible spread of the cancer with an MRI machine over time. PCI is radiation therapy that is delivered to the brain in hopes of preventing spread of cancer into the brain. The use of brain MRI alone may reduce side effects of receiving PCI and prolong patients' lifespan. Monitoring with MRI scans alone (delaying radiation until the actual spread of the cancer) may be at least as good as the combination of PCI with MRI scans.
Recruiting2 awards Phase 322 criteria
Proton Therapy vs Photon Radiation
for Esophageal Cancer
This trial studies how well proton beam radiation therapy compared with intensity modulated photon radiotherapy works in treating patients with stage I-IVA esophageal cancer. Proton beam radiation therapy uses a beam of protons (rather than x-rays) to send radiation inside the body to the tumor without damaging much of the healthy tissue around it. Intensity modulated photon radiotherapy uses high-energy x-rays to deliver radiation directly to the tumor without damaging much of the healthy tissue around it. It is not yet known whether proton beam therapy or intensity modulated photon radiotherapy will work better in treating patients with esophageal cancer.
Recruiting2 awards Phase 31 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University of Cincinnati Cancer Center-West Chester?
University of Cincinnati Cancer Center-West Chester is a medical facility located in West Chester, Ohio. This center is recognized for care of Skin Cancer, Uterine Tumors, Relapse, Stomach Cancer, Lung Cancer and other specialties. University of Cincinnati Cancer Center-West Chester is involved with conducting 122 clinical trials across 238 conditions. There are 26 research doctors associated with this hospital, such as Davendra P. Sohal, Trisha Wise-Draper, MD,PhD, Emily Curran, MD, and Shuchi Gulati, MD FACP.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.